




Frank McCaney, Strata Skin Sciences Inc: Profile & Biography - Bloomberg


































































  

























Feedback





Frank McCaney

President/CEO,
Strata Skin Sciences Inc






Career History




President/CEO
Strata Skin Sciences Inc, 11/2016-PRESENT


Founder
NB Therapeutics Inc, PRESENT


Chief Executive Officer
Corpak Medsystems, UNKNOWN-11/2016


Vice President
Viasys Healthcare Inc, 10/1998-4/2001


Vice President
Diametrics Medical Inc, 1995-1998


Various Management Positions
Boehringer Mannheim Corp, 1990-1995


Senior VP:Business Development
Viasys Healthcare Inc, 4/2001-UNKNOWN


President/CEO/Founder
NB Therapeutics Inc, FORMER


Show More









Website:
www.strataskinsciences.com






Corporate Information
Address:

100 Lakeside Drive
Suite 100
Horsham, PA 19044
United States


Phone:
1-215-619-3200


Fax:
1-215-619-3208


Web url:
www.strataskinsciences.com











From The Web












Memberships



Board Memberships




Strata Skin Sciences Inc


Board Member, PRESENT









Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data





















































































CORPAK MedSystems Acquires Maxter Catheters






































Skip to content










Together: Your Preferred Enteral Partner




Main Menu



 





(Back to previous page)


CORPAK MedSystems Acquires Maxter Catheters

November 17, 2014



CORPAK MedSystems, Inc., a global leader in Enteral access technologies, announced today that it has acquired the business of Marseille, France based Maxter Catheters. The acquisition enhances CORPAK’s research, development, and manufacturing capabilities and enables CORPAK to better serve global markets.
Bernard Daurelle, the founder and CEO of Maxter Catheters said, “We are thrilled to gain broader market access for our leading medical products by leveraging CORPAK’s commercial success and global reach.”
According to Tom Kuhn, President/COO for CORPAK, “We are confident that Maxter’s talented employees will bring unique expertise and experience to CORPAK and that all stakeholders will benefit from the broader CORPAK ingenuity and strength.”
Frank J. McCaney, CEO of CORPAK added, “CORPAK is committed to providing the most comprehensive range of products for patients requiring enteral therapy. Maxter’s existing products will complement our offerings and adding Maxter’s skill in innovation and rapid development to our already impressive capabilities will enhance the growth of CORPAK and increase our value to our customers around the world.”
Among Maxter Catheter’s current products are the ENTRAL™ and ENTRAL-VAC™ range of enteral feeding and aspiration tubes, enteral syringes, adapters, and accessories.
CORPAK Medsystems, Inc. is a portfolio company of Linden Capital Partners.
About CORPAK MedSystems
CORPAK MedSystems is a leading global medical device company focused on Enteral access technologies. With more than 30 years of experience and a strong record of innovation, CORPAK partners with customers and stakeholders to create clinical and economic solutions, enabling better patient outcomes.
About Linden Capital Partners:
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.
About Maxter Catheters
Established in 1996, Maxter Catheters is specialized in the development and production of disposable medical devices. Maxter Catheters offers a wide range of gastric feeding and aspiration tubes for adults, pediatrics, and neonates designed and manufactured using state-of-the-art technological equipment. Maxter also develops new products for the latest medical techniques.
Contact:
Jeff Nordquist, Vice-President, Global Marketing, CORPAK MedSystems (847-304-3476)
www.CorpakMedsystems.com
www.maxter-catheters.com















 



























   Frank McCaney | CORPAK MedSystems Inc | ZoomInfo.com


Frank J. McCaney - Patents







 


  FREE patent keyword monitoring and additional FREE benefits.  REGISTER now for FREE 
 




    

















  



Browse Inventors:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z






    SEARCH FreshPatents:   
  | Online Background Check



Frank J. McCaney patentsRecent bibliographic sampling of Frank J. McCaney patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title): 10/06/11 - 20110245759 - Methods of treating an infection with nitric oxideThe present invention provides methods of treating bacterial, viral, protozoan, parasitic, arthropod and fungal infections by applying gaseous nitric oxide to a patient having an infection. The present invention further provides improved methods of treating bacterial, viral, protozoan, parasitic and fungal infections by applying gaseous nitric oxide, in combination with... Inventors: Frank J. Mccaney, Alex Stenzler (Cardinal Health 207, Inc.)
Cardinal Health 207, Inc.Archived* (*May have duplicates - we are upgrading our archive.)
  	20110245759 - Methods of treating an infection with nitric oxide ###The bibliographic references displayed about Frank J. McCaney's patents are for a recent sample of Frank J. McCaney's publicly published patent applications. The inventor/author may have additional bibliographic citations listed at the USPTO.gov. FreshPatents.com is not associated or affiliated in any way with the author/inventor or the United States Patent/Trademark Office but is providing this non-comprehensive sample listing for educational and research purposes using public bibliographic data published and disseminated from the United States Patent/Trademark Office public datafeed. This information is also available for free on the USPTO.gov website.  If Frank J. McCaney filed recent patent applications under another name, spelling or location then those applications could be listed on an alternate page. If no bibliographic references are listed here, it is possible there are no recent filings or there is a technical issue with the listing--in that case, we recommend doing a search on the USPTO.gov website. ###Sign up for the FreshPatents.com FREE Keyword Monitor and check for keyword phrases (ie. "RFID" , "wireless", "web development", "fuel cells" etc.)...You will be notified when new patent applications and inventions are published that match your keywords. Also you can save for later research public patent/invention documents using our FREE Organizer. It takes only 30 seconds to sign up or login.Advertise on FreshPatents.com - Rates & Info###Design/code © 2014 FreshContext LLC/Freshpatents.com.Patent data source: patents published by the United States Patent and Trademark Office (USPTO)Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and may contain additional data/images. FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents and there may be applicable trademarks or servicemarks within the documents.FreshPatents.com Support - Terms & Conditions











MCCANEY, FRANK J & ELLEN C New Jersey Property Records





FRANK MCCANEY New Jersey Property Information









 



Home
Search by owner
Complete List
Most Expensive
Contact Us
Random Property...










Owner Name: MCCANEY, FRANK J & ELLEN C

Street Address: 10 PROGRESS PL City State: VOORHEES NJ Zip Code: 080433300 County: camden County District: VOORHEES TWP Block: 00218  43 A numerical identification representing a tax map block number as it appears on the tax list. The block is nine characters, up to a five character block number and a four character block suffix.  Lot: 00001 A numerical identification representing a tax map lot number as it appears on the tax list. The lot is nine characters, up to a five character lot number and a four character lot suffix. Land Value: 97200 The assessed value of the site.  Improvement Value: 236100 The assessed value of the all improvements to the site.  Net Value: 333300 The value of the land plus the improvement value minus limited exemptions. Prior Year Net Value: 425500 Prior Year Net Value Current Year Tax: 0 Current Year Tax Last Year Tax: 12301.21 This field indicates the prior year net amount of tax. The decimal point is assumed. 
(This field is for towns that bill on a calendar year only.  Deduction Amount: 0 Lists the total dollar amount of deductions on the parcel. Deed Date: 1988-05-20 This is the date of deed for the sale of a property Sale Assessment: 55000 This field is for the assessment of the property at the time of the sale. Sale Price: 188400 This field shows the sales price indicated on the deed. The number one (1) indicates a nominal consideration sale.  Transaction Date: 2013-02-09 Indicates the last date a change was made to a particular block and lot. Transaction Update No.: 0932 The number of the accepted transaction listing for the last change to a particular block and lot.  Property Class: Residential An alpha-numeric field which identifies real property by use.  Property Location: 10 PROGRESS PL This is the actual street address of the parcel.  Building Description: 2SF-O/B Codes describe the physical characteristics of the property. The information should be listed in the 
following order: stories, exterior structural material, style, number of stalls and type of garage.  Land Description: 0.31 AC This alpha-numeric field accepts the size of the parcel in square feet, acres or actual dimensions.  Calculated Acreage: 0.31 Lists the size of the parcel in acres. This field is automatically calculated from the land description field. Zoning: 75 This alpha-numeric field describes the zoning designations of the parcel.  Tax Map Page Number: 2507 Lists the page on which the parcel can be found on the district tax maps.  Number Of Owners: 0 This field represents the number of owners of a property where a property tax deduction exists.  Bank Code: 00000 A numeric code indicating the name of the lending institution holding a mortgage on the parcel.  Deed Book: 04296 Indicates the book number where the current deed is filed.  Deed Page: 00035 Indicates the page number where the current deed is filed.  School Tax Overage: 0 School Tax Overage Percent Owned Code: 100% 1=10%, 2=20%, 3=30%, blank=100%.  Exempt Property List Own: 00 A numeric code identifying owner, purpose and specific use. This field is only mandatory for exempt 
property.  Exempt Property List Use: 00 Exempt Property List Use Exempt Property List Desc.: 000 Exempt Property List Description Year Constructed: 1988 This field indicates the year the building was constructed.  Special Tax Code 1: F03 Special Tax Code 1: F-Fire Exemption Amt. 1: 0 Exemption Amount 1 Exemption Amt. 2: 0 Exemption Amount 2 Exemption Amt. 3: 0 Exemption Amount 3 Exemption Amt. 4: 0 Exemption Amount 4 Senior Citizens Count: 0 Senior Citizens Count (S) - $250 
 Veterans Count: 0 Veterans Count (V) - $250  Widows Count: 0 Widows Count (W) - $250 
 Surviving Spouse Count: 0 Surviving Spouse Count (R) - $250  Disabled Count: 0 Disabled Count (D) - $250  Rebate Response Flg: N Rebate Response Flag -N=No tenant rebate required, Y=tenant rebate notice is required 
 Rebate Base Year: 2012 This field indicates the base year for tenant rebate purposes. 
 Rebate Base Year Tax: 12301.21 This field indicates the taxes that were paid in the tenant rebate base year.  Rebate Base Year Net Value: 425500 This field indicates the net assessment of the property in the tenant rebate base year.  Non Municipal Half 1: 0 This field indicates the net amount of non-municipal taxes for the first half of the current tax year. Non Municipal Half 2: 0 This field indicates the net amount of non-municipal taxes for the second half of the current tax year.  Municipal Half 1: 0 This field indicates the net amount of municipal taxes for the first half of the current tax year. Municipal Half 2: 0 This field indicates the net amount of municipal taxes for the second half of the current tax year.  Non Municipal Half 3: 0 Non Municipal Half 3 - This field is rarely used. Municipal Half 3: 0 Municipal Half 3 - This field is rarely used. 
 Estimated Quarter3 Tax: 0 This field indicates the third quarter bill is based on a percentage of last yearâs taxes before the tax rates 
have been determined.  Statement Of State Aid Amt.: 0 Statement Of State Aid Amount Court Records Search: FRANK MCCANEYClick to run a court records search for FRANK MCCANEY now If your content is displayed on this page and you would like it removed for any reason, you may opt-out at any time by submitting a opt-out request

View Nearby Properties 

SILVER, SCOTT A & BETH A22 PROGRESS PL
	
      

WALLACE JR, ARNOLD & LORI J26 PROGRESS PL
	
      

SALVATORE, BLASE E & NORMA A30 PROGRESS PL
	
      

SPENCE, JEFFREY B34 PROGRESS PL
	
      

HORNSTEIN, CHARLES & KERRY38 PROGRESS PL
	
      

TAWADROS, ROSALIE A42 PROGRESS PL
	
      

THAKUR, MANOJ S & ROSHNI M46 PROGRESS PL
	
      

BRADIS, ROBERTA C50 PROGRESS PL
	
      

IBISI, DILAVER & AYSE401 KRESSON RD
	
      

  DISCLAIMER: By using this site, you certify that you will use any information obtained for lawfully acceptable purposes.  Information contained herein is derived from records that may have errors and/or not always be accurate or complete. Data is sometimes entered poorly, processed incorrectly and may not be free from defect. This system should not be relied upon as definitively accurate. Before relying on any data this system supplies, it should be independently verified. This information is not to be used for any purpose described in the fair credit reporting act (FCRA). All searches are subject to legal restrictions, terms of use, and applicable law. All of this information is the representation of the management of the entities providing us this data. All content provided is deemed to be in the public domain. 





NAVIGATION


Home
Search by owner
Complete List
Most Expensive
Contact Us
Random Property...





© Copyright 2015 records.estate.PRIVACY POLICY







Insider Trading - Mccaney Frank J - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Mccaney Frank J





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-28Purchase
2016-11-284:57 pm
Strata Skin Sciences Inc.
SSKN
Mccaney Frank JPresident & CEODirector
20,000
$0.5053
$10,106
20,000(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-31Option Award
2016-11-015:22 pm
N/A2026-10-31
Strata Skin Sciences Inc.
SSKN
Mccaney Frank JPresident & CEODirector
542,500
$0.55
542,500(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 08:04:38 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Frank J. McCaney: Executive Profile & Biography - Bloomberg










































  





















































































July 23, 2017 9:04 AM ET
Healthcare Equipment and Supplies

Company Overview of Strata Skin Sciences, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Frank J. McCaney  Chief Executive Officer, President and Director, Strata Skin Sciences, Inc.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.See Board Relationships62$207,973As of Fiscal Year 2016
Background

		Mr. Frank J. McCaney has been Chief Executive Officer and President at Strata Skin Sciences, Inc. since October 31, 2016. Mr. McCaney serves as Chief Operating Officer of Ceretec, Inc. He served as the Chief Executive Officer of CORPAK MedSystems, Inc. He served as the Chief Executive Officer of Corpak Medsystems UK Limited. He founded Nitric Bio, Inc. (also known as Theranox, Inc., Nitric BioTherapeutics) and served as its President and Chief Executive Officer since ... April 2006 until 2012. He served as Senior Vice-President of Business Development of CareFusion 202, Inc. (VIASYS Healthcare Inc.) since April 2001 and served as President of its Tecomet and Thermedics businesses since November 2002. From October 1998 to April 2001, Mr. McCaney served as Vice President of Global Marketing. From October 1996 to October 1998, he was Director of Business Development of Diametrics Medical, Inc. Mr. McCaney serves as a Director of Corpak MedSystems, Inc. and Diasome Pharmaceuticals Inc. He has been a Director at Strata Skin Sciences, Inc. since October 31, 2016. He served as a Director of Nitric Bio, Inc. until 2012.Read Full Background




Corporate Headquarters
100 Lakeside DriveHorsham, Pennsylvania 19044United StatesPhone: 215-619-3200Fax: 215-619-3209
Board Members Memberships
2016-PresentChief Executive Officer, President and DirectorStrata Skin Sciences, Inc.
Education
				There is no Education data available.
				Other Affiliations
CareFusion 202, Inc.CORPAK MedSystems, Inc.Nitric Bio, Inc.Ceretec, Inc.Corpak Medsystems UK Limited


Annual Compensation
Salary$56,700Total Annual Compensation$56,700
Stocks Options
All Other Compensation$1,000Unexercisable Options$108,500Total Number of Options$310,000
Total Compensation
Total Annual Cash Compensation$57,700Total Short Term Compensation$56,700Other Long Term Compensation$1,000Total Calculated Compensation$207,973




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationGene S. Cartwright Ph.D.Chief Executive Officer, President, Acting Chief Financial Officer and DirectorGuided Therapeutics, Inc.$255.0KMichael P. Oliver Chief Executive Officer, President, Chief Operating Officer and DirectorSpectraScience, Inc.$325.0KL. Michael Hone Chief Executive Officer and DirectorCaliber Imaging & Diagnostics, Inc.$350.0KArchie  Fraser Chief Executive OfficerOptiscan Imaging Limited$22.0KThomas A. Braun BA, J.D., LLMChief Executive Officer, President and DirectorVerisante Technology Inc.$312.5KCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Strata Skin Sciences, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Francis J. McCaney - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Francis J. McCaney

Age : 62Public asset : 9,720 USDLinked companies :  STRATA Skin Sciences Inc 





Summary 



Mr. Francis J. McCaney is on the Board of Directors at STRATA Skin Sciences, Inc., Diasome Pharmaceuticals, Inc. and Omnipacs LLC. Mr. McCaney was previously employed as President, Chief Executive Officer & Director by NB Therapeutics, Inc., a Principal by Baxter Healthcare Corp., a Principal by Boehringer Mannheim Diagnostics Corp., Chief Executive Officer by CARDINAL HEALTH 208, INC, and Vice President-Global Marketing by Thermo Biomedical, Inc.



Current positions of Francis J. McCaney 









 NameTitle
Since
 STRATA Skin Sciences Inc(Advanced Medical Equipment & Technology)
President, Chief Executive Officer & Director
2016Diasome Pharmaceuticals, Inc.
Director
-Omnipacs LLC
Director
-



Holdings of Francis J. McCaney 










 NameEquities%Valuation

 STRATA Skin Sciences Inc (SSKN) Advanced Medical Equipment & Technology 4,0000.16%9,720 USD



Francis J. McCaney: Personal Network 







 NameLinked companies

David K. Stone STRATA Skin Sciences Inc 

Jeffrey Francis O'Donnell STRATA Skin Sciences Inc 

Samuel E. Navarro STRATA Skin Sciences Inc 

Kathryn B. Swintek STRATA Skin Sciences Inc 

LuAnn Via STRATA Skin Sciences Inc 

Christina L. Allgeier STRATA Skin Sciences Inc 

James L Coyne STRATA Skin Sciences Inc 

Jay Sturm STRATA Skin Sciences Inc 

Richard E. Caruso Diasome Pharmaceuticals, Inc. 

Anthony J. Dimun STRATA Skin Sciences Inc 




Most Read News 




07/17 CHARLES SCHWAB : Low-fee BlackRock funds reel in cash but earnings disappoint



07/17DJCHARLES SCHARF : Bank of New York Mellon Names Former Visa Executive Scharf CEO and Chairman



07/17 PHILIP GREEN : You're hired - UK 'Apprentice' star Brady to chair Philip Green's company



07/17DJRUPERT MURDOCH : Tesla Names James Murdoch and Linda Johnson Rice to Board -- Update



07/17DJJAMES MURDOCH : Tesla Names James Murdoch and Linda Johnson to Board of Directors



07/18DJMARK LIGHT : Top Company News of the Day



07/18DJNELSON PELTZ : Peltz Goes on Offense In Break From Form -- WSJ



07/17 DAVID HENRY : Didn't pay your Macy's bill? Expect a text from Citigroup



07/17DJMARK LIGHT : Top Company News of the Day



07/17DJNELSON PELTZ : Peltz Seeks P&G Board Seat -- WSJ



More news

 


            © 2017 People and Ownership :    









Advertisement








Francis J. McCaney : Connections 



 STRATA Skin Sciences Inc









David K. StoneJeffrey Francis O'DonnellSamuel E. NavarroKathryn B. SwintekLuAnn ViaChristina L. AllgeierJames L CoyneJay Sturm




 Dextera Surgical Inc









Samuel E. Navarro




 BioSig Technologies Inc









Jeffrey Francis O'Donnell




 Integra Lifesciences Holdings Corp









Richard E. Caruso




Trice Medical, Inc.
                                            








Jeffrey Francis O'Donnell





Surgical Laser Technologies, Inc.
                                            








Jeffrey Francis O'Donnell





Two Ten Footwear Foundation
                                            








LuAnn Via





Trice Orthopedics, Inc.
                                            








Jeffrey Francis O'Donnell





NB Therapeutics, Inc.
                                            








Jeffrey Francis O'Donnell





Ivy Sports Medicine LLC
                                            








Anthony J. Dimun





Songbird Holdings LLC
                                            








Richard E. Caruso





PAKA Pulmonary Pharmaceuticals, Inc.
                                            








David K. Stone





Nascent Enterprises LLC
                                            








Anthony J. Dimun





The Baum School of Art
                                            








Richard E. Caruso





Altherx, Inc.
                                            








Jeffrey Francis O'Donnell





Community Bank Delaware
                                            








Richard E. Caruso





Replication Medical, Inc.
                                            








Jeffrey Francis O'Donnell





EchoCath, Inc.
                                            








Anthony J. Dimun





Smart Personalized Medicine LLC
                                            








Richard E. Caruso





Gen9, Inc.
                                            








David K. Stone





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Lloyd Blankfein
Michael Bloomberg
Yannick Bollor�
Warren Buffett
Antony Burgmans
Jean-paul Clozel
Gary Cohn
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Michel Landel
Daniel Loeb
Maurice L�vy
Jack Ma
Marissa Mayer
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
Xavier Niel
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Urs Rohner
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  












 














Slave





